Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 28th, 2022
Ronald C. Minkoff Quoted in Law360 on NY Rule Forcing Settlement Talks Before Trial
Commercial Litigation Partner Ronald C. Minkoff was quoted in the article, “New NY Rule Forces Settlement Talks Before Trial” published by Law360. The article discusses Rule 30, which forces parties to attend a court-ordered settlement conference at a critical stage of dispute — after the discovery phase of a case has completed and before a trial begins — where additional efforts are required to reach a settlement. Ron discussed the benefits of the new rule.
Ron said Rule 30 provides, "exactly the settlement opportunity parties need."
"While no one can force a party to settle, or to even actively engage in the settlement process, this rule makes a party think long and hard before they reject the process and gives both parties the ability to engage in settlement talks without showing weakness," Ron told Law360, adding that “The rule also allows the New York Supreme Court's commercial division to compete favorably, not just with other judicial forums, but with arbitration as well.”
Additionally he said, "A rule like this will provide litigants with another reason to prefer the Commercial Division over arbitration.
Read the article here.
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
